Extrahepatic Cancer Suppresses Nuclear Receptor-Regulated Drug Metabolism

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-3289
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Extrahepatic Metabolism of Zidovudine.

British Journal of Clinical Pharmacology
Pharmacology
1992English

Drug Screening to Target Nuclear Orphan Receptor NR4A2 for Cancer Therapeutics

Translational Lung Cancer Research
Oncology
2017English

Med1 Subunit of the Mediator Complex in Nuclear Receptor-Regulated Energy Metabolism, Liver Regeneration, and Hepatocarcinogenesis

Gene Expression
GeneticsMolecular Biology
2014English

The Orphan Nuclear Receptor LXR Is Positively and Negatively Regulated by Distinct Products of Mevalonate Metabolism

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1997English

Androgen-Regulated Metabolism and Biosynthesis in Prostate Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2014English

Control of Metabolism by Nutrient-Regulated Nuclear Receptors Acting in the Brain

Journal of Steroid Biochemistry and Molecular Biology
Molecular MedicineCell BiologyMolecular BiologyBiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2012English

Butein, a Tetrahydroxychalcone, Suppresses Cancer-Induced Osteoclastogenesis Through Inhibition of Receptor Activator of Nuclear Factor-kappaB Ligand Signaling

International Journal of Cancer
Cancer ResearchOncology
2011English

Nuclear Receptor Coregulators in Cancer Biology

Cancer Research
Cancer ResearchOncology
2009English

Farnesoid X Receptor Suppresses Lgr5+ Cancer Stem Cell Proliferation

Cancer Discovery
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy